Get the latest news on Biocept stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on BIOCQ performance

Latest Biocept Stock News | OTC:BIOCQ | Benzinga

Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Comments

Biocept Stock News

News

Latest Biocept Stock News | OTC:BIOCQ | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga